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MI us controls. For HindIll, lho homorygola (~ 1” ) froquonoy 0160 wns nal 
inorensod In MI (0.7% OR _ 1 ,l) cr CAD pl (8.31, OR 9 O.fS). 
Conclusron: Common LPL polvmarphmma nro not nssoclntod wcth lnrgo 
lncreasos tn nsk (OR 1 1,s) for CAD or MI. Howovor, smallor ovemll risk. 
or rxlbgroup apoc~kc nskR (~a, In woman), nro nal excluded. nnd should bo 
furlher avnlunlad. 
P, Rodrlgu@8, M, do Lurdaa Andmda, .I. Coucele, J. Amvodo, M,I, Porelrn. 
I, Arrojn, T. Vax, I. Oil, 0, Sl\vn, 8, lXmr\a, V. Amu)o, L. Guermmx M dn 
Grnqn Marnln, 00~ E!&?qulmlca, Fat QOnclns Mddkm, Unh! Now? do 
LMKM, Slsrvl~as Cnfdinlq~gln, 0 EnnrlacrhNagrn, Mmp “Ep3.q Manir: 
LWm, Canfro do Cflordralo~fn do PhrIwilo, tb.sp f%rlmrrTtb Fhrftf~nl 
The rolnllanahlp bnlwoon nlhorognnanla nnd lhrombagonc~slri IA wall oslnb, 
llahod and wldnly roconnlrod. Tho plnsmn loval al Ilpoprolain (n) - Lp(a) . 
hnl w dlrecl lnvolvomanl an lha pnlhophyalullrgy al coronnry orlary dlaonso 
(CAD). lhmuah 118 dunl mlo OR n lrnn8porl nnd lnlorncllon pnrlcclo an lhn 
andolhallnl wall. Wo as#umo lhnl lha hlghor tha plnnmn lavol ol Lp(o) nnd 
amnllar lhs moloculnr shucluro ol npoprololn (n) . Ape (a), more aoatly Cp(n) 
cnn axpmsla IIR pnthaQania atlaot. IAO Lp(a) wnn avnktdnd III a papulnhon al 
43 pin wllh cllnlcnl dlo6nnnls ol CAD, maan ago 7hR 1 II yta (!iB-HI yes), 40% 
mnlw gondor. dlvldod nccardlng lo lnoronwng dogroan at CCS clnstxltanhon 
snd thapmnnnco olocalo myocnrdiol Inlnmllon (AMI) Alhomllonlc lp(o) VW 
Idbnllflad, gsnollcnlly dobxmlnod wilh aavaral I8omorphlc fatma - lso Lp(n) 
. whloh warn dallnad m tormn 01 lho mimbor ol knnglos. I8olp(a) can bo 
dlvlded In lwa groupw, dopandlng on ila dlmanslona nnd ponolrnbng co+xl!y 
01 lhn ondalhelinl wnll. laoLp(n) wllh rmnll dlmonslona (Qroup I; n a 20 pls) 
. IloLp(a) p, B, 81 nnd S2. mpmsonl Iho parllclaa wtlh highor ponolraling 
CapnClly ‘n mu &xlnl wnll. whllo tha laoLp(n) wllh gronlor dlmonstons and 
IawQr pnnolmling cnpnclly . laoLp(o) S3. SO nnd S 4 . wow included In 
the rocond (amup (Qroup II: n m 23 pla). laoLp(n) nm doloclod by spocd~c 
and highly Roloc1lvo blochomlcnl tochnlqua lollawod by tmrnunoblo~llng and 
nnzymallc dofacllon Totnl Choloshxol (Chol), LP rich In Chol (LDL. HDL. 
HDl-2). Lp(a) nnd nn~l.phosphollpld nn\l.bodias (APA) warn do\ormmod. 
Tho Isomorphic spoclas In c~rculnhng Lp(n) wllh small dlmensmns h~vo 
a htighor nlhorogorvc polonhnl IhOl IS cllroclly rolnlod wllh 11s ponolralmg 
cnpnclty nnd nccurnulnllon wllhm Iho nrl@nal wnll. Paltenls wllh more sovero 
clinical oxpross~on 01 CAD hnvo mom lroqucnt small Isomorphtc Apo (a) 
and lhls could have palho-physlologtc Impllcaltons m lho progrosslon and 
growing ot Inlra-coronnry nlharomdous los1ons 
1065-14 Human Qaraoxwase (PONA) Qenotype 
Determlnes the Susceptlblllty to Oxldatlon of 
High-Density Llpoproteln (HDL) Particle 
Y. Walnnnbo. H. Ohmurn. M. Snwano. Ii Mokuno. Ii Daida. Ii Yamaguchl. 
Junfendo Ufl~vrrs~fy Tbkyo, Japan 
t3ackground~ PONA IS a HDL nssoclaled enzyme thal hydrolyze organphos- 
phales. carboxyllc acids osler. and carbamnlo. Recently the assoclallon 01 
coronary attory dlsonse (CAD) and PONA achvlty woro reported. and PONA 
genolype IS consldemd as a new coronary nsk factor. In lhls study we inves- 
hgated lho PONA genotype and suscopllblltly lo ouldallon of kpoprotems lo 
elucidate the contnbulion of PONA to alherosclerosls 
Mefhods: We analyzed 134 pahonls who underwent coronary anglogra- 
phy in our hospllnl. DNA were obtained from patients blood and PCR-RFLP 
methods were used lo determine the GlnlArg polymorphfsm 01 PONA. Gcno- 
type frequency ot AJA, A/B, B/B were 26 9%. 35.1?,. 38.1%. respectively. 
L!poprotelns were obtained lrom pahenls al least 12 hours fastmg and were 
separated with soquontlal ullracenlilugalion. We analyzed TBARS and the 
conhnuous momlonng 01 copper Induced oxidallon using 5 ,iM CuSO4 and 
100 rtg pmleln of each llpoprotems al 37C among the groups of three geno- 
typo. 
&%ulfs: TEARS levels ol plasma. VLDL. nnd LDL did not differ among 
the groups. but HDL TEARS were significantly higher in A/A than A/E or B/B 
(1.013. 0.616. 0.562 nM MDA/mg protein, p = 0.014). In A/A, LDL lag-hme 
was slightly shorter than A/B or 818 (43.2. 46.6. 46.0 min., p = 0.051). also 
HDL lag-lime was significantly shorter than A/B or B/B (16.4, 21.9.20.1 mm., 
P = 0.005) There was no ditference 01 CAD prevalence among the groups 
(A/A = 7S0.. AIE = 74O,. BIB = ES%). 
JACC’ . I;chnl;~n IVOX 
Conckfsion: PONA gonolype clonrly delermmed the axrdnkvo modilicnlton 
al HDL pnnlclo. Although wa lnllad IQ conlirm the assooielion of PONA germ 
lypo nnd CAD In the prosonl oludy, PONA mny plny a role In pnthogenasls 
al nlharosclarosir via HDL oxidnlion, 
11065-l 5 1 Llpoproteln Llpato Qens Polymorphbm8: 
Asroclatlone With Coronary Artery Dltwaso and 
Llpoproteln l.svel@~ In Japnna$c Populntlon 
M. Snwnna, Y. Wntnnnba. H. Ohmum. K. Shimadn. Il. Mokuna, H. Pnlda, 
l-l. Ynmnguoh13 JwWxfa Uniwarfy Tolip& &Ipan 
&dgmun@ In twmo provim~s ahidies, sevsrnl rosttickon fmgmenl longlh 
polymorphisms (RFLP8) in Iba lrpopmloin kpnsa (LPI.) gene were nrrsocialod 
wilh camnnry adory disenno (GAD) and plasma lIpid lavsk Rut it 18 bsa 
clonrty nslbkahed in Jopnnbso populaban. In thi8 r&!dy, we QUamiM?d Ihe 
dis~nbullon al the LPI. palymorphiams in a Jnpnneso population and the 
nnaocinllons bslwuen cl% polymorphisms (Hind III. Pvrr II) and CAD, plasma 
llpld lovols 
&fof))od? All pnlconle (n a 209, IOn males) wore undorwonl coronary 
nngiogmphy. CAD+ was dolmcd as .Sll% solnosts in nl @sl one ot mayor 
branch ot cnronnry nrlory (CAR+ = 146) Tho Hmd lll/Fvu II genotypas were 
nnnlyrod by 17CR RFLPa. 
Ff&sitlb’ Tho tmqwwioa PI Iho II2 and P2 alleles (“2” dcnolos presence 
ol cutlmg RIIQ) wore O.BO nnd 0.713. raspeclivo~y. Tha H2HP gwotypo was 
wgnilicnnlly more tmquonl in CAD+ lhan CAD (P . 001). The & II 
polymorphism showod no signikcan~ nssociallons wllh CAD H2H2 genotVpo 
nsaocinlod wilh slgnilicnn~ly lower levels ot HDL (P . 0.05) and Ape Al (P . 
0.05) thnn HlH2 + HlHl gonalypo. (43 t 16varsus 50 L 21 m@ll [mean 1 
SOl and lt2 i 23 vorw I22 t 2G mgtdl, respochvely). P2P2 geno~pe had 
nlso signileanlly lowor levels 01 HOL (P . 0.05) and Apo Al (P . 0.01) lhan 
PlP2tP2P2 gonolypo (43 t 1G versus 50 t 20 mgfdl and 112 t 22 velsus 
123 t 26 mgfdl, mspockvaly). Them were no other ass~~almns belween 
LPL RFlPs and olher kpoprolocn cumponenls 
Conclusrona- Tho rosulls ~uggoal lhal Hmd 111 polymorphism m the lP1 
gono contnbulos lo HDL cholostoml lovols and devclopmenl ol CAD 
( 1065-l 6 1 Recombinant Apollpoproteln A-Iuilam Protects 
Agalnst Lysophosphatldylcholine-induced 
Endothellal Dyafuncllon 
B.0 Coin. P.K. Shah, J. Yano. M.D. Molloy. B Cercek. S Kaul 
Cedars-Star A9ed1cal Centor. lm Angeles. CA. USA 
We pmvtously demonshaled anllalherogenlc effects 01 reconsllluled htgh 
dens@ kpoprole~n IHDL) usmg Iho recombmanl apokpoprotem (ape) A-l mu- 
lnnl. ap~A.lu,~,~~, (ApoM). complexed with the phosphokpld tamer DMPC In 
lhls study. we examined whelhcr ApoM has any ellecls on lysophosphalldyl- 
cholmo (LPQ~mduced lmpalrmcnl 01 endothekum-dependent vasodllalalmn 
Rosponses lo acelylcholmo (1 rlM) were oxammed m camlld arlenes lmm 
15 normal rabbIIs perlused in uctro belorc and aker mcubalion wllh LPC (50 
JIM) m absence and presence 01 apoM and wlld.lype ape A-l (ApoWT) cam- 
ploxcd wilh DMPC. plasma-donved HDL. free apoM (F-ApoM) (all 1 mgfml) 
and Iho carnor DMPC (30 rtgjml). Changes m dlameler were measured. 
and responses were oxpressed as % change m ckameter (mean t SD) of 
proconslricled arlenes. Basellne dlamcler 01 carotid arlenes was 2.9 t 0 1 
mm. ‘p I 0.05 vorsus.LPC control. 
LFC 
Canlrol 
63 ! 7 
APOM ApoWl 
60 * ,‘I 76 I 16 
HDL 
75 I II 
FAopM 
i7 : 22 
DMPC 
81 1 22 
l LPC 29 t 21’ 56 22 J6 : 26 36 ! 35 22 * 2’ 24 : 25’ 
N 9 9 6 5 5 5 
LPC had no ellects on sodium mlroprusslde-mediated vasodllalahon. 
Conc/usron- Apo A-lk,,,a”O and apo A-l wild-type-reconsh~uled HDL as well 
as plasma-derived HDL. but not free apoM or the earner DMPC. slgmlicantly 
allonuatcd LPC-induced lmpalrment of endothekum-dependent vasodllala- 
11on. The proleclwe effects of apoM and apoWT were more pronounced than 
plasma HDL. Thus, reversal 01 endothellal dysfuncllon by HDL may. in part. 
explain the Inverse relatlonshlp between HDL choleslerol and coronary heart 
disease. 
1065-l 7 Famlllal Hypercholesterolemla: The Limited 
Predictive Value of Plasma LDL-Cholesterol 
M.A W. Humans-Eckenhausen' . J.C. Defesche*. J.J.P. Kastelein?. ‘The 
StOEH. The Netherlands: ‘The Academic Medical Certfer. Amsterdam. The 
Netherlands 
Background: Demonslratlon of a mutation in the LDL-receptor gene conhrms 
Iho dragnosts Famrltal H~r&o1esbxoI~mra (FH). To assess 1h0 pmd1*Iw 
value of Iho sorum 1RLcholesI~ml only. Ih0 tollowmg slutty was conduced 
Melhods Blood snmples wcm prospoctlvely collpcmd on 990 CASSOCK 
IIM pftrllclpanls tn Iho n&h Nattonal Saocning program tor FH Persons 
roc01wng heotmcmt tar hypercholostorolomia wmo not included Both plasma 
LDL&olesImol rmmrpmont and RNA anrdysls were exeamd on all blood 
samplmi. 
Conc&r. The c@agnoers ot FH bv deformmatron gt plasma LRLcholes- 
t~rol onIy is rnarmrat0 atxJ leads to unnecessary mtadtagnosra (14% falee- 
positive) whit0 at It0 same trme a suhstzmhal number of FH paf~@nls ts n(rt 
det~whxl (21% talsc-rqatwe) and possrb& demed the aplrropnatc therapy 
jlogsl Dilated and Right Ventricular 
Cardiomyopathy 
Mcmaay. March 30, t998.3:UO p.m.-5-CKl p m 
Georgia World Congress Center, West Exhibit Hall Level 
Presentation Hour: 3X10 p.m.+00 p.m. 
1066-23 Tacmlimus-induced Cardiimyopettry: 
A Systematk Review of Over 3600 Adult Patients 
K C. Coley, M.&I Vemco. @.M. McNamara. S.C Park. M 0 Cressman 
R A. Branch Umversrly OC Prftsbu@ Rfe@rcal Center. Prtfs&rrgh. PA. USA 
Ba&grourrd Tacrolrmus I$ an rmmunosuppressant used lo prevent grab 
rem. RecentIy. several cases of hypertrophrc cardromyopathy (HCM) 
have been reported rn pedtatnc lransplanl patrents mng tacrolrmus me 
purpose of Ihrs study was to delermme Ihe prevalence and enotogy oI HCM 
m noacard,ac adult transpl2nt patrents recervmg tacmkmus 
A’ethods: We retmspectrvely rewewed our transplant database for non- 
cardrac transplant pahents recerwng lacrolrmus horn li82 to 4% Records 
01 3609 transplant recrprents (Irwzr = 2257. krdney = 1333. other = 19) were 
rcvtewed Patrents &lth tell ventncular hypertrophy (LVH) dehned as a pas- 
terror or septal wall thrckoess 1 3 cm by echocardography IECHO) were 
mdependently evaluated 
ffesu& Ot 846 patrents slth ECHOs. 171 had LVH. Patients were cat. 
egorued on the bass of eholo~ as valvular disease (3pe). hypeden%? 
disease (wa). tschemrc heart disease (16%). or muLtac!orat (15%) OrtIy 51x 
patrents were rdentrked rn whom no undertymg cause of HCM was eutden:. 
Conc/usron: TIx prevabnce of HCM m our tanokmus-lreated aduII tram- 
plant populatton rs srmllar IO that reported m general populatron shrdres Thgs 
data suggests that treahrenl wrlh tacrolrmus IS not a nsk factor for HCM 
1066-24 Lett Atria1 Systolic Function Is Depressed in 
Idiopathic and Preserved in lschemfc Dilated 
Cardiomyopathy 
F Tnposkradts. I. Moyssakts. N. Daftants. N. Stntegos, A Alhanassrou. 
T Makris. A Christodoulou. M. Kynaktdls. Urtrk@srg of Lansa. Facu/~ 01 
Medrcrne. Larrsa. Greece and Deparlment or Cardro/ogy Larkcl Howla! of 
Athens. Greece 
Background. Left atrial (LA) myopathy has been suggested tn rdropa!htc 
(ID) dilated cardiomyopathy (DC). We hypothesfzed that LA systdc tunctton 
would be depressed m IDDC compared to ischemtc DC (ISDC). 
Melhods: Seventeen paI!onts wrth IDDC. 16 wrth ISDC and 18 age and 
sex matched controls were studted. LA volumes were echocardlogmphtcally 
IDDC ISDC COlllf0l 
LAmdx (cm3im*)” 446? 136 462? 163 269!62 
LAp (cm3/mz Ia 346 f 134 30.6 * 109 167 : 37 
LAmn (cm3fm2)” 265r 116 21?91 107r25 
ACT& 016iOl 032 ? 0.1 036:Ol 
LVEDP (mmHg)” 166: 45 172.6 to : 4 - 
a ,DDC = ISDC Control. p 0 05. k IDDC ISDC Control. P 0 05. e IDDC 
ISDC = Control. D 0.05. LVEDP Lefl venlncular end-dm.slole WSSJW 
I P Clementa. W L. Ulbr. L J. Olson &yo etnnc Roch.0-< m, Um 
Raprd heart rate can affect adversely letl ventncular (LV) alecwon trmtgn 
(EF, ln Ontcr lo d0termm0 It restmg arckaccyclo length (CCL. mlrec) m- 
lluenced LVEF and hllmg. reslmg LVEF, peak tillhtg rate (PFA. stroke vo& 
urnemecl nnd wno IO peak hlkng rat0 (TPFR. maec) wer0 measured wart, 
gated b%udpool radronuclf& vontflculography and correlated (Table) wrm 
CCL In M1 patients wrm no cardrac pathology (NORMAL). 38 wrth 1-1~ 
dilated cardiomyopathy (IOM) conhrrmxl by cantrae cathetenzatron and 23 
wrth reduced LVEF and coronary ~Rery dwaare (CAD), m0an LVEF rn thes0 
three QlOlrps wer0 063 t 0 @a. 025 I 0.11 and 024 ? 000 respectwely 
and mean CCL was 690 I 172 752 i 161 amd 778 ? 194 rwpechvely 
NOR&t.4L loon CAD _ ._ .~~ 
LVEF 026. 056 036 
004 00003 009 
PFR 036 0 76 051 
OL?O% 0 O#l 003 
TPFR 023 r -- ‘) ” 
008 00#0 003 --- 
= I ua’ue *ml p value Lwlaw 
tt was concluded lhat m IDM me correlations between CCL, restrng VLEF. 
PFR and TPFR were moderately strong m IDM compared to NORMAL and 
CAD. we the srmllar LVEF m CAD. Thus. a short restmg CCL m IDM was 
mated wrth reduced LVEF and restrrxtlve hlkng. whereas a long CCL was 
assocrated tih presenred LVEF and more normal LV hllmg Restmg CCL 
and rhus heart rate may be a more cmical determmam of restmg LV hmctlon 
m KIM than m NORMAL and CAD 
11066-26 ] Congestive Heart FaIlwe In the Natural History ot 
Arrhythmogenic Right Ventricular 
Cardiomyopathy 
C 5asso. A. Angelrm. U LR~. A. Nava G Threne Oepk Pattrol~ 
cardrovascu/ar surgery arrd cafdroogy unlversrty of Pa&a ~&drc-a/ 
5cfmoi. Pad&?. lfaly 
Arrhythmogencc right venlncular cardtomyopathy (ARVC) rs characterized 
by omrnous veotrrcular arrhythmras due to Lbro.IaIIy replacement of the at. 
rophrc myocardrum. Palhologrc changes can be so wIdespread lo affect Ilm 
wtmle RV. with or wrthout IeIt venlncular (LV) mvolvemenl. as IO dofermm0 
congestwe heart tadure (CHF) We rewe+ed our coliectron of ARVC heartS 
to estabbsh clmrcopathologrcal features of paltents (pts) wrth CHF. Among 
40 cases. 10 (25%) had CHF (5 F. 5 M. age range 28-65. mean 42.3 yrs vs 
24.6 of the remarnmg pts. p . 0.001). Four dred bemuse of cardiac 0rmsl 
(2). cerebral (1) and pulmonary embolrsm II). 6 underwent to cardiac trans. 
piantalron due lo rehactory CHF An rn vwo ARVC dragnosrs was achreved In 
6. the remarmng 4 were mrsdragnosed as drlarcd cardromyopslhy Four had 
previous eplscdes of syslemlc emboksm Basal ECG showed alnal hbnllatr~ 
or flutter m 4. venlrrcular arrhylhmtas 01 IeII bundle b?lrtCh block type rn 3 and 
polymorphic m 7. T wave lmversron rn Vl up to V5 In 5 Mean heart wdght 
was 430 g (range 35odM)l: RV mlargemmlt w35 lNg0 m 5 and moxtemte 
IA 5. RV aneurysms rn 8 (94P.). mural Ihrombos1s of the RV tn 2 and of leh 
alnal appendage m 1 Al hlslology all cases showed lransmural ftbro-latIy 
replacemen with patchy mflammatory mflllrates. In conclusron. CHF may 
be the end-pomt m the natural hIstory 01 ARVC. Agedepondancy 01 Ihls 
clmrcal o~tcorne supports the theory of an acqurred progressive disease ‘* 
the sethng 01 bwentncular depressed contmctrlrty. ARVC may mlmrc dtlated 
cerdtomyopathy ac‘d head transplantafton conslrtutes the Only thcrapeutlc 
option. 
